Schedule 13G ownership disclosure
Galectin Therapeutics Inc
Security class unavailable · CUSIP: 363225202
Event date: 2015-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,587,300
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-081635
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Nov 27, 2015
- Reporting period
- Nov 20, 2015
- Description
- Schedule 13G beneficial ownership